C. Galli

C. Galli, M. Arcangeletti, F. Ferraglia, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.

C. Galli, V. Bossi, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

IgM anti-hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication.

C. Galli, C. Mancini, S. Angeletti, 1995, Clinical and diagnostic virology.

Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.

C. Galli, D. Flichman, F. D. Di Lello, 2020, Vaccine.

HTLV-III ANTIBODY AMONG ITALIAN DRUG ADDICTS

C. Galli, A. Zanetti, D. Geroldi, 1985, The Lancet.

Seroprevalence of hepatitis E virus in Argentinean blood donors

C. Galli, D. Flichman, F. D. Di Lello, 2020, European journal of gastroenterology & hepatology.

Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes

C. Galli, P. Pozzilli, E. Gale, 1987, Diabetologia.

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.

C. Galli, M. Landini, G. Dettori, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination.

C. Galli, S. Valverde, G. Gessoni, 2014, Blood transfusion = Trasfusione del sangue.

Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

C. Galli, A. Zanetti, L. Romanò, 2013, Blood transfusion = Trasfusione del sangue.

HTLV-II among Italian intravenous drug users and hemophiliacs

C. Galli, A. Zanetti, E. Tanzi, 1992, European Journal of Epidemiology.

A multicentric seroepidemiological survey of HTLV-I/II in Italy.

C. Galli, A. Zanetti, S. De Virgiliis, 1994, Clinical and diagnostic virology.

SARS-CoV-2 antibody performances: we need better criteria

C. Galli, M. Plebani, 2020, Clinical chemistry and laboratory medicine.

The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy

C. Galli, P. Lampertico, F. Ceriotti, 2020, Liver international : official journal of the International Association for the Study of the Liver.

What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?

C. Galli, E. Orlandini, S. Valverde, 2008, Journal of medical virology.

Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B.

C. Galli, N. Manca, C. Bonfanti, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc.

C. Galli, M. Brunetto, F. Oliveri, 1993, Journal of hepatology.

Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy.

C. Galli, G. Raimondo, C. Saitta, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Association between hepatitis C and hepatitis E viruses in southern Italy

C. Galli, Angela M. Coppola, F. Pisanti, 1994, The Lancet.

Clinical, epidemiological and virological features of acute hepatitis B in Italy

C. Galli, A. Zanetti, M. Clementi, 2015, Infection.

Hepatitis C virus outbreak in a haemodialysis unit: learning from failures.

M. Faccini, C. Galli, A. Zanetti, 2016, The Journal of hospital infection.

HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection

C. Galli, M. Plebani, P. Julicher, 2018, Clinical chemistry and laboratory medicine.

Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results.

C. Galli, F. Bonvicini, M. Zerbini, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease

C. Galli, B. Suligoi, S. Ciuta, 1999, European Journal of Epidemiology.

Fractionation and characterization of hydatid fluid antigens with identification of an antigen similar to human serum albumin.

V. Vullo, C. Galli, S. Delia, 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Echinococcus granulosus antigens: comparative analysis of human, bovine and ovine hydatid fluids.

V. Vullo, C. Galli, S. Delia, 1984, Annals of tropical medicine and parasitology.

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome

E. Sartori, C. Galli, S. Calza, 2012, Clinical chemistry and laboratory medicine.

Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy

G. Antonelli, C. Galli, P. Pagnotti, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of the Abbott AxSYM Cytomegalovirus (CMV) Immunoglobulin M (IgM) Assay in Conjunction with Other CMV IgM Tests and a CMV IgG Avidity Assay

M. Van Ranst, T. Lazzarotto, C. Galli, 2001, Clinical Diagnostic Laboratory Immunology.

CA 19-9: handle with care

C. Galli, M. Plebani, D. Basso, 2013, Clinical chemistry and laboratory medicine.

Avidity Index for Anti-HIV Antibodies: Comparison between Third- and Fourth-Generation Automated Immunoassays

C. Galli, B. Suligoi, N. Manca, 2011, Journal of Clinical Microbiology.

Serology of Treponema pallidum infection: methodological considerations and seroprevalence in selected Italian populations

C. Galli, P. Donati, Gruppo Italiano Studio Sierologia Infezione Luetica, 2008 .

Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory

C. Galli, D. Gregori, R. Maiavacca, 2010, Clinical chemistry and laboratory medicine.

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

C. Castilletti, M. Capobianchi, C. Galli, 2021, Clinical chemistry and laboratory medicine.

Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era.

C. Galli, A. De Luca, M. Re, 2021, The New Microbiologica.

Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay.

C. Galli, P. Pezzotti, G. Rezza, 2003, Journal of acquired immune deficiency syndromes.

In situ hybridization of human immunodeficiency virus (HTLV‐III) in cryostat sections of lymph nodes of lymphadenopathy syndrome patients

C. Galli, F. Pezzella, B. Macchi, 1987, Journal of medical virology.

Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis

C. Galli, V. Chulanov, A. Yankina, 2019, PloS one.

Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity.

L. Tavoschi, C. Galli, S. Buttò, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Accuracy of different thresholds for the anti-HIV avidity index

C. Galli, B. Suligoi, N. Manca, 2008 .

HIV avidity index performance using a modified fourth-generation immunoassay to detect recent HIV infections

M. Capobianchi, C. Galli, B. Suligoi, 2017, Clinical chemistry and laboratory medicine.

Performance of V3-based HIV-1 sero subtyping in HIV endemic areas.

L. Tavoschi, C. Galli, S. Buttò, 2011, Annali dell'Istituto superiore di sanita.

Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland.

L. Tavoschi, C. Galli, M. Almaviva, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management

C. Specchia, E. Sartori, C. Galli, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Seroprevalence of HTLV-I and HTLV-II.

C. Galli, A. Zanetti, 1992, The New England journal of medicine.

Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma.

L. Buscarini, C. Galli, E. Tanzi, 1992, Archives of virology. Supplementum.

Serum human epididymis protein 4 ( HE 4 ) and Risk for Ovarian Malignancy Algorithm ( ROMA ) as new diagnostic and prognostic tools for epithelial ovarian cancer management

E. Sartori, C. Galli, G. Ruggeri, 2011 .

Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state.

C. Galli, N. Caporaso, F. Morisco, 1998, Research in virology.

Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

C. Galli, A. Goglio, E. Tortoli, 1999, Diagnostic microbiology and infectious disease.

Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: a multiple regression analysis of risk factors.

L. Ravà, G. Ippolito, C. Galli, 1995, The Journal of hospital infection.

Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management

C. Specchia, E. Sartori, C. Galli, 2011, Cancer Epidemiology, Biomarkers & Prevention.